SecBot SecBot
144 ·Filed Jun 22, 2026

SEPN

Septerna, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed4mo ago SEC0001950047-26-006351
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This filing signals an insider's intent to take profits post-exercise. While the sale is not massive in absolute terms, the officer status and the recent cluster of insider sells (3 sells $621K in 30 days) warrant caution. Monitor for a follow-on Form 4 to confirm execution. The stock may face mild near-term selling pressure.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$36.57
T+0 close · Jun 22, 2026 · via day close
Latest settled
+5.11%
T+60 · $38.44
Vs SPY
+1.87%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 23 $36.57entry
  2. T+1 · 5mo ago −1.42%α −1.38% · $36.05
  3. T+5 · 5mo ago −4.98%α −5.99% · $34.75
  4. T+20 · 4mo ago −11.92%α −13.08% · $32.21
  5. T+60 · 2mo ago +5.11%α +1.87% · $38.44
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Jae Kim, an officer of Septerna, filed a Form 144 to sell 94,339 shares valued at approximately $3.3 million. The sale stems from a stock option exercise, and the insider intends to sell on the open market. Given the company's size and the insider's role, this is a moderately notable signal of potential insider profit-taking.

Key Facts

  • Officer Jae Kim filed a Form 144 to sell 94,339 shares of common stock.
  • The proposed sale value is approximately $3.3 million based on the filing date.
  • The sale is related to a stock option exercise, not a secondary market purchase.
  • The filing date is June 22, 2026, and the sale is intended to occur soon.
  • As a percentage of market cap, the sale is roughly 0.2% ($3.3M / $1.6B).
  • Recent insider activity shows 3 sells totaling $621K in the last 30 days, making this a larger-than-average individual sale.

Financial Impact

Sale of ~$3.3 million worth of stock, approximately 0.2% of market cap. Not a controlling stake liquidation but a meaningful signal from an officer.

dilutioninsider sentiment

Risk Factors

  • Potential for insider sentiment to weigh on stock near-term as profit-taking is executed.
  • If additional insiders follow suit, could signal broader skepticism about valuation.
  • The sale may be tax-motivated or for personal diversification, reducing its predictive value.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006351
Document: 0001950047-26-006351-index.html0001950047-26-006351
Document: 0001950047-26-006351.txt0001950047-26-006351

US Market Status

Market Closed · Opens Wed (11h 50m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 22, 2026